Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Surgical procedure involving removal of \>= 2 impacted third molars with bone removal required for at least 2 of the 3 impacted third molars~* At least moderate pain within 5 hours after oral surgery procedure~* Sufficiently alert to follow directions, communicate with study personnel and perform study procedures~* If female, using an acceptable method of birth control and has a negative urine pregnancy test~Exclusion Criteria:~* Previously treated patients who have discontinued treatment due to an adverse event~* Patients who have had inadequate pain relief from tramadol HCl/acetaminophen or tramadol~* Patients who have used pain medication (other than anesthesia) within 24 hours of receiving study medication, any long-acting over-the-counter pain medications within 3 days, or any pain medication after finishing oral surgery~* Patients with known problems with taking opioid medications or acetaminophen~* Patients with a history of abusing drugs or alcohol~* Patients with an uncontrolled medical condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).